Comparison between preoperative and postoperative concurrent chemoradiotherapy for rectal cancer: an institutional analysis
Jeong Won Lee, Jong Hoon Lee, Jun-Gi Kim, Seong Taek Oh, Hyuk Jun Chung, Myung Ah Lee, Hoo Geun Chun, Song Mi Jeong, Sei Chul Yoon, Hong Seok Jang
Radiat Oncol J. 2013;31(3):155-161.   Published online 2013 Sep 30     DOI: https://doi.org/10.3857/roj.2013.31.3.155
Citations to this article as recorded by Crossref logo
PTEN and P-4E-BP1 might be associated with postoperative recurrence of rectal cancer patients undergoing concurrent radiochemotherapy
Heng Zhang, Xiaofan Li, Wanjun Sun, Haoren Qin, Haipeng Li, Hao Yan, Huaqing Wang, Xipeng Zhang, Shiwu Zhang, Hui Wang
BMC Cancer.2024;[Epub]     CrossRef
Association of cancer diagnosis with disability status among older survivors of colorectal cancer: a population-based retrospective cohort study
Shiming Zhang, Lin-Na Chou, Michael D. Swartz, Hemalkumar B. Mehta, James S. Goodwin, Yong-Fang Kuo, Sharon Hermes Giordano, Carole A. Tucker, Karen M. Basen-Engquist, Elizabeth J. Lyons, Brian Downer, Susan K. Peterson, Tru Cao, Maria C. Swartz
Frontiers in Oncology.2024;[Epub]     CrossRef
Evaluación de la respuesta patológica al tratamiento neoadyuvante en cáncer de recto. Experiencia del Instituto de Cancerología de Medellín (Colombia, 2011-2017)
L.J. Palacios-Fuenmayor, A.M. Naranjo-Isaza, C.A. Serna-Ortiz, D.A. Mosquera-Castro, L.M. Arbeláez-Leon, L.R. Gómez-Wolff, H.I. García-García, L.A. Sánchez-Patiño
Revista de Gastroenterología de México.2021; 86(1): 13.     CrossRef
Evaluation of the pathologic response to neoadjuvant treatment in rectal cancer. Experience at the Instituto de Cancerología de Medellín (Colombia, 2011-2017)
L.J. Palacios-Fuenmayor, A.M. Naranjo-Isaza, C.A. Serna-Ortiz, D.A. Mosquera-Castro, L.M. Arbeláez-Leon, L.R. Gómez-Wolff, H.I. García-García, L.A. Sánchez-Patiño
Revista de Gastroenterología de México (English Edition).2021; 86(1): 13.     CrossRef
Sarcopenia is poor prognostic factor in older patients with locally advanced rectal cancer who received preoperative or postoperative chemoradiotherapy
Song Ee Park, In Gyu Hwang, Chang Hwan Choi, Hyun Kang, Beom Gyu Kim, Byung Kwan Park, Seong Jae Cha, Joung-Soon Jang, Jin Hwa Choi
Medicine.2018; 97(48): e13363.     CrossRef
Preoperative chemoradiotherapy versus postoperative chemoradiotherapy for stage II–III resectable rectal cancer: a meta-analysis of randomized controlled trials
Jin Ho Song, Jae Uk Jeong, Jong Hoon Lee, Sung Hwan Kim, Hyeon Min Cho, Jun Won Um, Hong Seok Jang
Radiation Oncology Journal.2017; 35(3): 198.     CrossRef
Is lateral pelvic node dissection necessary after preoperative chemoradiotherapy for rectal cancer patients with initially suspected lateral pelvic node?
Min Ju Kim, Sung Chan Park, Tae Hyun Kim, Dae Yong Kim, Sun Young Kim, Ji Yeon Baek, Hee Jin Chang, Ji Won Park, Jae Hwan Oh
Surgery.2016; 160(2): 366.     CrossRef
Significance of histologic tumor grade in rectal cancer treated with preoperative chemoradiotherapy followed by curative surgery: A multi-institutional retrospective study
Jin Ho Song, Sung Hwan Kim, Jong Hoon Lee, Hyeon Min Cho, Dae Yong Kim, Tae Hyun Kim, Sun Young Kim, Ji Yeon Baek, Jae Hwan Oh, Taek Keun Nam, Mee Sun Yoon, Jae Uk Jeong, Kyubo Kim, Eui Kyu Chie, Hong Seok Jang, Jae Sung Kim, Jin Hee Kim, Ki Mun Kang
Radiotherapy and Oncology.2016; 118(2): 387.     CrossRef
Seven low-mass ions in pretreatment serum as potential predictive markers of the chemoradiotherapy response of rectal cancer
Kangsan Roh, Seung-Gu Yeo, Byong Chul Yoo, Kyung-Hee Kim, Sun Young Kim, Min-Jeong Kim
Anti-Cancer Drugs.2016; 27(8): 787.     CrossRef
Preoperative chemoradiotherapy followed by transanal local excision for T3 distal rectal cancer: A case report
SEUNG-GU YEO
Experimental and Therapeutic Medicine.2016; 11(4): 1465.     CrossRef
Association of pretreatment serum carcinoembryonic antigen levels with chemoradiation-induced downstaging and downsizing of rectal cancer
SEUNG-GU YEO
Molecular and Clinical Oncology.2016; 4(4): 631.     CrossRef
Carcinoembryonic antigen has prognostic value for tumor downstaging and recurrence in rectal cancer after preoperative chemoradiotherapy and curative surgery: A multi-institutional and case-matched control study of KROG 14-12
Jong Hoon Lee, Dae Yong Kim, Sung Hwan Kim, Hyeon Min Cho, Byoung Yong Shim, Tae Hyun Kim, Sun Young Kim, Ji Yeon Baek, Jae Hwan Oh, Taek Keun Nam, Mee Sun Yoon, Jae Uk Jeong, Kyubo Kim, Eui Kyu Chie, Hong Seok Jang, Jae-Sung Kim, Jin Hee Kim, Bae Kwon Je
Radiotherapy and Oncology.2015; 116(2): 202.     CrossRef
KRAS Mutation Status Is Not a Predictor for Tumor Response and Survival in Rectal Cancer Patients Who Received Preoperative Radiotherapy With 5-Fluoropyrimidine Followed by Curative Surgery
Jeong Won Lee, Jong Hoon Lee, Byoung Yong Shim, Sung Hwan Kim, Mi-Joo Chung, Bong-Hyeon Kye, Hyung Jin Kim, Hyeon Min Cho, Hong Seok Jang
Medicine.2015; 94(31): e1284.     CrossRef
Is elective inguinal radiotherapy necessary for locally advanced rectal adenocarcinoma invading anal canal?
Seung-Gu Yeo, Hyeon Woo Lim, Dae Yong Kim, Tae Hyun Kim, Sun Young Kim, Ji Yeon Baek, Hee Jin Chang, Ji Won Park, Jae Hwan Oh
Radiation Oncology.2014;[Epub]     CrossRef
Carbohydrate Antigen 19-9 Levels Associated with Pathological Responses to Preoperative Chemoradiotherapy in Rectal Cancer
Seung-Gu Yeo, Dae Yong Kim, Tae Hyun Kim, Sun Young Kim, Ji Yeon Baek, Hee Jin Chang, Ji Won Park, Jae Hwan Oh
Asian Pacific Journal of Cancer Prevention.2014; 15(13): 5383.     CrossRef
Respuesta clínica completa postneoadyuvancia en cáncer de recto estadio III: observación o cirugía
Pilar Adriana Torres Mesa
Revista Colombiana de Gastroenterología.2014; 29(4): 391.     CrossRef